MedicarePartD.guide

A non-government resource built from CMS public data

Emgality on Horizon Medicare Blue Rx Standard (S5993-001)

galcanezumab

Covered, with prior authorization required.

Tier 3 (preferred brand). Quantity limit of 2 per 30 days.

$266.23
Patient pays / month, after deductible
$770.53
Patient pays / month, before the $615.00 deductible
$798.70
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap

EMGALITY 120 mg/mL Injection, Solution at a preferred retail pharmacy, from the plan's negotiated price of $1,479.08 for a month. Other covered strengths are listed below.

Prior authRequired on all 3 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 3 covered strengths and forms
FormTierPatient pays / monthLimits
EMGALITY 120 mg/mL Injection, Solution3$269.97PA · 2 per 30 days
EMGALITY 120 mg/mL Injection, Solution3$266.23PA · 2 per 30 days
EMGALITY 100 mg/mL Injection, Solution3$327.69PA · 3 per 30 days

Other CGRP migraine drugs on this plan

Verify with the plan before prescribing or filling. Member services: (800)391-1906. Data from the CMS 2026 Part D formulary and pricing files. Full plan details

Plan ID s5993-001